Clinical outcomes and recurrence patterns in pancreatic ductal adenocarcinoma diagnosed at an early stage: insights from a multicenter cohort study in Japan
Patients with early-stage PDAC exhibit a higher risk of remnant pancreatic recurrence than those with stage II disease. These findings underscore the importance of long-term pancreas-focused surveillance in early-stage PDAC to enable timely detection of late recurrence and potentially improve patients outcomes.
Authors
- Koji Arihiro (ORCID: https://orcid.org/0000-0001-9544-4832)
- Tamito Sasaki
- Shinya Nakamura (ORCID: https://orcid.org/0000-0002-3263-7271)
- Akihito OKAZAKI
- Kenichiro Uemura
- Teruo Mouri
- Bunjiro Noma
- Juri Ikemoto (ORCID: https://orcid.org/0000-0003-3992-0472)
- Yoshifumi Fujimoto
- Yasutaka Ishii (ORCID: https://orcid.org/0000-0003-3545-8743)
- Tomoyuki Minami (ORCID: https://orcid.org/0000-0002-0464-0633)
- Shinya Takahashi
- Shiro Oka
- Keiji Hanada
- Atsushi Yamaguchi
- Masanobu Yukutake
Institutions
- Hiroshima University (JP)
- Hiroshima General Hospital (JP)
- Hiroshima City Asa Citizens Hospital (JP)
- Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital (JP)
- Hiroshima Prefectural Hospital (JP)
- Hiroshima University Hospital (JP)
- Kure Kyosai Hospital (JP)
- Higashihiroshima Medical Center (JP)
- Chugoku Rosai Hospital (JP)
- Kure Medical Center (JP)
- Onomichi General Hospital (JP)
Publication Details
- Journal
- Journal of Gastroenterology
- Published
- 2026-01-03
- DOI
- https://doi.org/10.1007/s00535-025-02340-x
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00